299 related articles for article (PubMed ID: 19190211)
1. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
Carmona-Fonseca J; Alvarez G; Maestre A
Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
[TBL] [Abstract][Full Text] [Related]
2. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
3. [Plasmodium vivax malaria: treatment of primary attacks with primaquine, in three different doses, and a fixed dose of chloroquine, Antioquia, Colombia, 2003-2004].
Carmona-Fonseca J; Alvarez G
Biomedica; 2006 Sep; 26(3):353-65. PubMed ID: 17175999
[TBL] [Abstract][Full Text] [Related]
4. Primaquine for prevention of malaria in travelers.
Baird JK; Fryauff DJ; Hoffman SL
Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
[TBL] [Abstract][Full Text] [Related]
5. [Methemoglobinemia in patients with Plasmodium vivax receiving oral therapy with primaquine].
Ferreira ME; Gomes Mdo S; Vieira JL
Rev Soc Bras Med Trop; 2011; 44(1):113-5. PubMed ID: 21340422
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
7. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days.
Carmona-Fonseca J; Maestre A
Acta Trop; 2009 Nov; 112(2):188-92. PubMed ID: 19653988
[TBL] [Abstract][Full Text] [Related]
12. [Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine].
Santana MS; da Rocha MA; Arcanjo AR; Sardinha JF; Alecrim WD; Alecrim Md
Rev Soc Bras Med Trop; 2007; 40(5):533-6. PubMed ID: 17992408
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India.
Dua VK; Sharma VP
Ann Trop Med Parasitol; 2001 Oct; 95(7):655-9. PubMed ID: 11784418
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects.
Ebringer A; Heathcote G; Baker J; Waller M; Shanks GD; Edstein MD
Trans R Soc Trop Med Hyg; 2011 Oct; 105(10):568-73. PubMed ID: 21890160
[TBL] [Abstract][Full Text] [Related]
15. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
[TBL] [Abstract][Full Text] [Related]
18. [Widespread use of primaquine for control of Plasmodium vivax epidemics in a population with varying degrees of G6PD deficiency].
Kondrashin AV; Baranova AM; Sergiev VP
Med Parazitol (Mosk); 2010; (4):24-8. PubMed ID: 21400709
[TBL] [Abstract][Full Text] [Related]
19. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
[TBL] [Abstract][Full Text] [Related]
20. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
Thriemer K; Poespoprodjo JR; Kenangalem E; Douglas NM; Sugiarto P; Anstey NM; Simpson JA; Price RN
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008838. PubMed ID: 33175835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
